Bio-Rad Labs (BIO) Tops Q2 EPS by $1.10, Misses on Revenue; Offers Q3 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $372.18 -3.18%
Revenue Growth %: -0.5%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -0.5%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.11, $1.10 better than the analyst estimate of $2.01. Revenue for the quarter came in at $638.5 million versus the consensus estimate of $645.79 million.
GUIDANCE:
Bio-Rad Labs sees Q3 2024 revenue of $638.5-681.1 million, versus the consensus of $661 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
- Cboe Global Markets (CBOE) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
